BCL2L11 and acute lymphoblastic leukemia: Moreover, co-treatment of ALL-7CL with dexamethasone and 5-azacitidine caused a significant increase in BIM expression after 48 h, compared to ALL-7CL treated only with dexamethasone (however, it was pretreated with 5-azacitidine for 3 days prior to dexamethasone).